Exposure to a matrix of prescription drugs and combination of treatments.
We're developing an assay to provide oncologists with a Drug Activity Ranking to aid them with cancer therapy selection based on available FDA-approved drugs.
We're using patient-derived cells to attempt to replicate the patient's malignancy ex-vivo and test their tumorous cells with drugs and drug combinations to better understand their potential toxicity.
Functional assays to provide key
actionable data derived from
patient samples to oncologists
Functional assays to provide key actionable data derived from patient samples to oncologists
OP's Functional Assay Platform
Analysis of drug response patterns.
OncoPrecision’s Proprietary Drug Activity Ranking